Sort
64,565 grants matching “drug discovery”
NF2-associated meningiomas: From omics discovery to targeted therapy
$649,818Vijaya Ramesh · Massachusetts General Hospital · R01 · FY2020 · NS
Discovery of Novel TLR Ligands with Adjuvant Properties
$649,771Vaxinnate Corporation · R43 · FY2004 · AI
Identification of novel secondary metabolites produced by symbiotic Proteobacte
$649,768Jon Clardy · University Of Wisconsin-Madison · U19 · FY2015 · AI
Reconfigurable microfluidic assay platform for molecula*
$649,766Peter Russell Charles Gascoyne · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · EB
TriadWeb: An easy-to-use web-based platform for protein engineering
$649,727Barry D Olafson · Protabit, Llc · R44 · FY2016 · GM
Engineering alternative splicing programs to accelerate maturation of stemcell-derived neurons
$649,638Hynek Wichterle · Columbia University Health Sciences · R01 · FY2025 · NS
Molecular Photoacoustic Imaging for Diagnostics and Therapy Monitoring
$649,539Richard R. Bouchard · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · EB
Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED)-CCC
$649,490Francis X McCormack · University Of Cincinnati · U01 · FY2020 · HL
Research Training in Academic Medical Oncology
$649,322Michael Davies · University Of Tx Md Anderson Can Ctr · T32 · FY2024 · CA
High Content Screening of Mycobacterium Tuberculosis
$649,245Tanya Parish · Seattle Children'S Hospital · R01 · FY2019 · AI
Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)
$649,242Louise Sumner · Gryphon Scientific, Llc · N01 · FY2021 · AI
Creation of in vivo active chemical probes for CAMKK2 to treat cancer
$649,225David Harold Drewry · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA
High throughput multidimensional chemoproteomics for function-directed covalent target discovery
$649,181Keriann Marie Backus · University Of California Los Angeles · R61 · FY2025 · CA
Signal Transduction by Tyrosine Phosphorylation
$649,169Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2014 · CA
Multi-tissue high-throughput proteomic and genomic study in Parkinson's Disease
$649,168Bruno A. Benitez · Beth Israel Deaconess Medical Center · R01 · FY2022 · NS
Alzheimer Disease Genetic Architecture in African Americans
$649,129Lindsay A. Farrer · Boston University Medical Campus · R01 · FY2016 · AG
TUMOR SENSITIZATION TO PURINE ANALOGS BY E.COLI PNP
$649,075Southern Research Institute · U19 · FY2000 · CA
Lead optimization and target identification of drugs targeting hypnozoites
$649,072Dennis E Kyle · University Of Georgia · R01 · FY2024 · AI
It's a tug of war: structure, consequences, and inhibition of CXCR4 and ACKR3 responses to lymphocyte chemoattractant CXCL12
$649,061Tracy M Handel · University Of California, San Diego · R01 · FY2025 · AI
Sulfonimidamides: New Frontiers in Stereochemistry and Functionality
$649,045Jared T Shaw · University Of California-Davis · · FY2023 · MPS
Identification of metabolic alterations during cortical development in a human cellular model for 22q11.2 deletion syndrome
$649,040Anca Mirabela Pasca · Stanford University · R01 · FY2022 · MH
Targeting RIPK3 in Age-Related Inflammation and Injury
$648,995Alexei Degterev · Tufts University Boston · R56 · FY2018 · AG
Scott & White Community Clinical Oncology Program
$648,992Lucas Wong · Scott And White Memorial Hospital · U10 · FY2008 · CA
Nucleocytoplasmic transport and nuclear pore disruption in ALS/FTD
$648,990Jeffrey D Rothstein · Johns Hopkins University · R01 · FY2017 · NS
Targeting Nuclear HSF1 as a Novel Anti-HCMV Strategy
$648,986Gary Ching Tao Chan · Upstate Medical University · R01 · FY2024 · AI